BioPharma Credit (LON:BPCP) Trading 0.6% Higher - Time to Buy?

Key Points

• BioPharma Credit PLC experienced a 0.6% increase in stock price, trading at GBX 67.40 ($0.90) with a total volume of 27,500 shares, significantly lower than its average volume.
• The company has a market capitalization of £1.00 billion, a PE ratio of 9.61, and a beta of 0.22, indicating lower volatility compared to the market.
• BioPharma Credit primarily invests in interest-bearing debt assets secured by royalties from approved life sciences products, highlighting its focus on the biotech sector.

BioPharma Credit PLC (LON:BPCP - ) traded up 0.6% on Thursday . The stock traded as high as GBX 67.40 ($0.90) and last traded at GBX 67.40 ($0.90). 27,500 shares changed hands during trading, a decline of 62% from the average session volume of 72,430 shares. The stock had previously closed at GBX 67 ($0.90).

BioPharma Credit Stock Performance

The firm has a market cap of £1.00 billion, a PE ratio of 9.61 and a beta of 0.22. The firm has a fifty day simple moving average of GBX 65.64 and a two-hundred day simple moving average of GBX 66.41.

About BioPharma Credit

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.